GO develops mainly in the context of an autoimmune condition, Graves disease, in which thyrotropin receptor (TSHR) activation by thyroid-stimulating antibodies mimics the action of TSH, producing hyperthyroidism (1, 2). The gene discussed is TSHR; the disease is geroderma osteodysplastica.